First blood test to help diagnose brain injuries gets Us Ok


The move means Banyan Biomarkers can commercialize its test, giving the San Diego-based company an edge in the biotech industry's race to find a way to diagnose concussions. The test doesn't detect concussions, but instead measures two proteins present in brain cells.



from Biotech News